Order Article Reprints

Tsakonas G, Martín-Bernabé A, Rounis K, Moreno-Ruiz P, Botling J, De Petris L, Ylipää A, Mezheyeuski A, Micke P, Östman A, et al. High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC. Cancers. 2021; 13(13):3151. https://doi.org/10.3390/cancers13133151

Tsakonas, Georgios, Alfonso Martín-Bernabé, Konstantinos Rounis, Pablo Moreno-Ruiz, Johan Botling, Luigi De Petris, Antti Ylipää, Artur Mezheyeuski, Patrick Micke, Arne Östman, and et al. 2021. "High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC" Cancers 13, no. 13: 3151. https://doi.org/10.3390/cancers13133151

Tsakonas, G., Martín-Bernabé, A., Rounis, K., Moreno-Ruiz, P., Botling, J., De Petris, L., Ylipää, A., Mezheyeuski, A., Micke, P., Östman, A., & Ekman, S. (2021). High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC. Cancers, 13(13), 3151. https://doi.org/10.3390/cancers13133151